No Data
No Data
US stock market anomaly | Conduit (CDT.US) soared 130% before the market, reaching a drug licensing agreement with AstraZeneca (AZN.US).
Conduit has reached licensing agreements with Astrazeneca for three experimental therapies.
AstraZeneca Licensing Deal Boosts Conduit Pharma
Express News | Conduit Pharmaceuticals Inc - AstraZeneca to Receive Conduit Stock
Conduit Pharmaceuticals Enters Into Exclusive License Agreement With AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
EXCLUSIVE: Penny Stock Conduit Pharmaceuticals Inks Licensing Pact With AstraZeneca For Multiple Assets
Express News | EXCLUSIVE: Conduit Pharmaceuticals Tells Benzinga 'Assets Have Shown Favorable Preclinical and Phase I Data. Conduit to Initiate Phase II Clinical Trials'
No Data
Yort E : Me too
股海踏浪 : A total of $5 or a share of $5? What if AstraZeneca offers to buy CDT? That is, the opening is $10 per share![dollar 💵](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f4b5.png)